Fasina O
Department of Ophthalmology, College of Medicine, University of Ibadan, Ibadan, Nigeria.
Afr J Med Med Sci. 2013 Jun;42(2):165-9.
Rhabdomyosarcoma (RMS) is the most common soft tissue sarcoma, and the commonest primary orbital malignancy in children. Studies on ophthalmic RMS are scanty in Nigeria, and other parts of Africa. This study thus describes the pattern of ophthalmic RMS in Ibadan and treatment outcome.
A retrospective, non-comparative, consecutive, interventional analysis of patients with ophthalmic RMS in an ocular oncology unit of a teaching hospital over 20 years was carried out.
Records of 22 patients, 15 males and 7 females, aged 2 months to 50 years (Median 7 years, Range 5-13 years) were analyzed. All patients presented with visual loss, orbital swelling and proptosis. Histological examination revealed embryonal RMS in 16 (72.7%) patients, alveolar in three (13.6%), pleomorphic in two (9.1%) and "not otherwise stated" in one (4.5%). Treatment outcome was poor as only two (9.1%) patients remained tumour-free 12 and 36 months after diagnosis. Three (13.6%) patients died on admission, while two (9.1%) patients are presently undergoing treatment. Fifteen (68.2%) patients were lost to follow-up, financial constraint and perceived poor response to treatment being the main reasons for incomplete and inconsistent treatment regimen and resultant poor outcome.
Demography and morphology of ophthalmic RMS in Ibadan is comparable to other studies. However, treatment outcome remains poor, mainly due to late presentation, incomplete and inconsistent treatment. Strengthening the national health insurance scheme to cater for the indigent and increased public enlightenment on early presentation of cases may go a long way in improving the outcome in our patients.
横纹肌肉瘤(RMS)是最常见的软组织肉瘤,也是儿童最常见的原发性眼眶恶性肿瘤。在尼日利亚和非洲其他地区,关于眼部RMS的研究很少。因此,本研究描述了伊巴丹眼部RMS的模式及治疗结果。
对一家教学医院眼科肿瘤病房20年来的眼部RMS患者进行回顾性、非对比性、连续性、干预性分析。
分析了22例患者的记录,其中男性15例,女性7例,年龄2个月至50岁(中位数7岁,范围5 - 13岁)。所有患者均出现视力丧失、眼眶肿胀和眼球突出。组织学检查显示,16例(72.7%)患者为胚胎型RMS,3例(13.6%)为肺泡型,2例(9.1%)为多形性,1例(4.5%)为“未另作说明”型。治疗效果不佳,诊断后12个月和36个月时,只有2例(9.1%)患者无肿瘤。3例(13.6%)患者入院时死亡,2例(9.1%)患者目前正在接受治疗。15例(68.2%)患者失访,经济困难和认为治疗反应不佳是治疗方案不完整和不一致以及最终治疗效果不佳的主要原因。
伊巴丹眼部RMS的人口统计学和形态学与其他研究相似。然而,治疗结果仍然很差,主要是由于就诊晚、治疗不完整和不一致。加强国家医疗保险计划以照顾贫困人口,并加强公众对早期病例就诊的认识,可能对改善我们患者的治疗结果大有帮助。